MedTrace Logo

Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema

NCT02107209 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-11-11

No results posted yet for this study

Summary

The clinical utility of bronchoscopic methods for achieving lung volume reduction has been evaluated in patients with advanced emphysema because these procedures are uniformly safer than surgical volume reduction. These include one-way valves, or bronchial occlusive devices to collapse emphysematous regions of lung and bronchial fenestration with bypass stents to improve expiratory flow, wire coils implants that compress the airway and thermal vapor ablation that causes an acute injury with subsequent fibrosis and reductions in volume.

Conditions

  • Pulmonary Emphysema

Interventions

PROCEDURE

Bronchoscopic Lung volume reduction

Fiberoptic bronchoscopy is used to inject the biological agents into the targeted lung segment

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmad Saad El-Morsi, Prof · Chest Medicine Department, Faculty of Medicine, Mansoura University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-04-30
Completion
2015-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02107209 on ClinicalTrials.gov